Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats.
Previous work from this laboratory has revealed that female rats acquired cocaine self-administration at a faster rate than male rats and that a greater percentage of females acquired self-administration [Psychopharmacology 144 (1999) 77.]. It has been suggested that sex differences in stimulant self-administration may be related to ovarian hormones, particularly estrogen. To investigate this possibility, we compared four groups (n = 10) of female rats: ovariectomized (OVX) treated with either estradiol benzoate (EB) or vehicle (VEH), and sham-operated intact (SH) females treated with either the antiestrogen tamoxifen (TAM) or VEH. An autoshaping procedure was used to train rats to lever press for intravenous infusions of cocaine (0.2 mg/kg). The criterion for cocaine acquisition was a mean of 100 self-administered infusions over five consecutive 6-h sessions. Results revealed that 70% of the OVX + EB group and 80% of the SH + VEH group acquired self-administration, while only 30% of the OVX + VEH group and 50% of the SH + TAM group met the acquisition criterion. Rats that had estrogen chemically or surgically blocked exhibited significantly less responding for cocaine over the acquisition testing period, and fewer of these rats met the acquisition criterion compared to intact rats and to OVX rats with estrogen (EB) replacement. The percentages for females with estrogen (70% and 80%) vs. those without (OVX, 30%) were similar to those reported for intact females (70%) and males (30%) in the previous study [Psychopharmacology (2000)]. Taken together, these results suggest that estrogen is a key factor influencing drug-seeking behavior in female rats, and it may underlie sex differences in drug-reinforced responding.
Lynch
W J
WJ
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC 27103, USA. wlynch@wfubme.edu
Roth
M E
ME
Mickelberg
J L
JL
Carroll
M E
ME
D000818:Animals; D016739:Behavior, Addictive / Q000378:metabolism*; D003042:Cocaine / Q000008:administration & dosage*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000502:physiology*; D005260:Female; D007262:Infusions, Intravenous; D010052:Ovariectomy; D051381:Rats; D017208:Rats, Wistar; D012646:Self Administration; D013629:Tamoxifen / Q000494:pharmacology
D018765:Dopamine Uptake Inhibitors; D004965:Estrogen Antagonists; D004967:Estrogens; D013629:Tamoxifen; C074283:estradiol 3-benzoate; D004958:Estradiol; D003042:Cocaine